Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Fujifilm, Dr. Reddy's End Generics JV in Japan | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Fujifilm, Dr. Reddy’s End Generics JV in Japan

Companies plan to explore other partnership opportunities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Corp. and Dr. Reddy’s Laboratories Ltd. have terminated the Memorandum of Understanding (MoU) to establish a joint venture in Japan for a generic drugs business.
 
The MoU, signed in July 2011, involved conducting detailed studies on the establishment of a joint venture for developing and manufacturing generic drugs in Japan. The two companies plan to explore other partnership opportunities such as API development and manufacturing, contract R&D and manufacturing, and the development and marketing of “super-generics.”
 
GV Prasad, chairman and chief executive officer, Dr. Reddy’s, said, “Unfortunately, we will not be able to partner with Fujifilm specifically for generic formulations business in Japan. However, I want to reinforce our commitment towards a planned entry into Japan to bring affordable and innovative drugs to more patients worldwide.”
 
Takatoshi Ishikawa, Fujifilm’s director corporate vice president and general manager of its Pharmaceutical Products Division, said, “In the long term we will be focusing more on priority fields such as new drugs in cancer field, more value-added super-generic, and bio-related business by using our core technologies: analysis technologies, original nanotechnology, and high reliability and high quality manufacturing technologies. Meanwhile, we will continue future collaboration with Dr. Reddy’s in other fields.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters